Business Type: Manufacturer, Trading Company, Distributor/Wholesaler
Employees Total 5
Annual Revenue US$2.5 Million - US$5 Million
used to treat nerve damage caused by hereditary transthyretin amyloidosis, a rare and slow-progressing disease caused by a buildup of proteins in organs and tissue.
